2Cronin P, Dwamena BA, Kelly AM, et al. Solitary pulmo- nary nodules: meta-analytic comparison of cross-sectional imaging modalities for diagnosis of malignancy [ J]. Radiol- ogy, 2008, 246 (3) : 772 - 782.
3Burant CF, Bell GI. Mammalian facilitative glucose trans- porters: Evidence for similar substrate recognition sites in functionally monomerie proteins [ J]. Biochemistry, 1992, 31 (42): 10414 - 10420.
4Rogers S, Macheda ML, Docherty SE, et al. Identification of a novel glucose transporter-like protein-GLUT-12 [J]. Am J Physiol Endocrinol Metab, 2002, 282 (3) : 733 - 738.
5Goo JM, Im JG, Do KH, et al. Pulmonary tuberculoma e- valuated by means of FDG PET: findings in 10 cases [J]. Radiology, 2000, 216 : 117 -121.
6Juergens KU, Weckesser M, Stegger L, et al. Tumor stag- ing using whole-body high-resolution 16-channel PET-CT: does additional low-dose chest CT in inspiration improve the detection of solitary pulmonary nodules? [J]. Eur Radiol, 2006, 16 : 1131 -1137.
7Davis SL, Nuermberger EL, Um PK, et al. Noninvasive pulmonary 18F-2-fluoro-deoxy-D-glucose positron emission tomography correlates with bactericidal activity of tuberculo- sis drug treatment [ J ]. Antimicrob Agents Chemother, 2009, 53 (11) : 1478 - 1488.
8Kim IJ, Lee JS, Kim SJ, et al. Double-phase is F-FDG PET-CT for determination of pulmonary tuberculoma activity [J]. Eur J Nucl Med Mol Imaging, 2008, 35 (4) : 808 - 814.
9Tian J, Yang X, Yu L, et al. A muhicenter clinical trim on the diagnostic value of dual-tracer PET/CT in pulmonary lesions using 3 '-deoxy-3'-18 F-fluorothymidine and 18 F-FDG [J]. J Nucl ned, 2008, 49 (2): 186 -194.
10Hara T, Kosaka N, Suzuki T, et al. Uptake rates of lSF- fluorodeoxyglucose and 1, C-choline in lung cancer and pul- monary tuberculosis * a positron emission tomography study [J]. Chest, 2003, 124 (3):893-901.
